EUROPE BIOBANK WEEK 2022 ROADSHOW | 13-14 October 2022, Rome

EUROPE BIOBANK WEEK ROADSHOW 22

FIRST STOP REGENSBURG (GER)

• 19-20 September
• Regensburg, Germany

ON THE ROAD TO HIGH QUALITY – WITH BIOBANKS IN THE FAST LANE

ESBB and BBMRI-ERIC invite you to the first Europe Biobank Week Roadshow Meeting & Exhibit held at the University of Regensburg, Germany, 19 -20 September 2022. This EBW22 Roadshow meeting is organized by ESBB and BBMRI-ERIC in partnership with the University of Regensburg, the “1. Bavarian Biobank Day” and the BRoTHER Summer School. The Meeting will be kicked off with a keynote by Carolyn Compton (US) followed by the sessions:

• The Bumpy Road to Accreditation

• Roadmap to Quality - A Guide to Reach the Aim of Accreditation

• Data Quality - More Than a Trailer

• Quality as a Driver for Biobank Innovations.

The event is framed by the first meeting of the Bavarian Biobank Network on the morning of the first day and the hands-on training of the BRoTHER Summer School in the afternoon of the second day. Enjoy the amazing scientific programme, meet and discuss with your peers at poster sessions and the networking event and exchange with companies at the exhibition. As member of ESBB and BBMRI-ERIC you benefit from a reduced registration fee!

All oral presentations are given by selected speakers only. However, submission of poster abstracts is very welcome. During the registration process you will be asked if you would like to submit a poster abstract. If you are interested, please have the author information and the poster abstract (250 words) ready for submission when registering!

SECOND STOP ROME (IT)

• 13-14 October
• Rome, Italy

The second stop of our EBW22 Roadshow will be in Rome (Italy), 13-14 October.

ESBB and BBMRI-ERIC organize this EBW22 Roadshow stop in partnership with the BBMRI ERIC Stakeholder Forum Patient Pillar, BBMRI.it, the Research Translational (IRCCS) Paediatric Bambino Gesù Hospital, and the paediatric network IDEA.

Paediatric (research) biobanking is a European priority asking for a scientific and Ethical-Legal-Societal-ELS shift within a Responsible Research & Innovation - RRI framework. Accordingly, our critical starting point will be an overall view of European commitment to paediatric research and healthcare and an in-depth exchange on good practices and priorities of various actors to raise awareness, facilitate assent and consenting processes, and improve engagement. Promoting practical solutions, we will address challenges of biobanking with children (earlier, over time, and following up), such as: how empowering new generations makes better research and a better research experience? Which tools to use to inform and increase the minor’s understanding? By whom is the child’s capacity (to understand, to assent) assessed? How to engage minors and their parents (guardians) over time and recognize them as active research participants?